<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ometendo</journal-id><journal-title-group><journal-title xml:lang="ru">Ожирение и метаболизм</journal-title><trans-title-group xml:lang="en"><trans-title>Obesity and metabolism</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2071-8713</issn><issn pub-type="epub">2306-5524</issn><publisher><publisher-name>Endocrinology Research Centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/omet9759</article-id><article-id custom-type="elpub" pub-id-type="custom">ometendo-9759</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Обзор литературы</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Инсулинорезистентность при ожирении: причины и последствия</article-title><trans-title-group xml:lang="en"><trans-title>Insulin resistance in obesity: pathogenesis and effects</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1429-8154</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лавренова</surname><given-names>Евгения Александровна</given-names></name><name name-style="western" xml:lang="en"><surname>Lavrenova</surname><given-names>Evgenia A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>научный сотрудник отдела фундаментальный и прикладных аспектов ожирения, эндокринолог-диетолог</p></bio><bio xml:lang="en"><p>Researcher, Department of Fundamental and Applied Aspects of Obesity</p></bio><email xlink:type="simple">lea07@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4453-8430</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Драпкина</surname><given-names>Оксана Михайловна</given-names></name><name name-style="western" xml:lang="en"><surname>Drapkina</surname><given-names>Oxana M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., профессор</p></bio><bio xml:lang="en"><p>MD, PhD, professor</p></bio><email xlink:type="simple">p310849@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Национальный медицинский исследовательский центр терапии и профилактической медицины</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Medical Research Center for Preventive Medicine</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>01</day><month>06</month><year>2020</year></pub-date><volume>17</volume><issue>1</issue><fpage>48</fpage><lpage>55</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Лавренова Е.А., Драпкина О.М., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Лавренова Е.А., Драпкина О.М.</copyright-holder><copyright-holder xml:lang="en">Lavrenova E.A., Drapkina O.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.omet-endojournals.ru/jour/article/view/9759">https://www.omet-endojournals.ru/jour/article/view/9759</self-uri><abstract><p>Распространенность ожирения в мире носит на сегодняшний день характер глобальной эпидемии. Являясь не только рецидивирующим, хроническим заболеванием, но и серьезным фактором риска, ожирение приводит к развитию и усугублению течения многих неинфекционных заболеваний. На фоне избытка и дисфункции жировой ткани при ожирении значительно возрастает риск развития таких заболеваний, как сахарный диабет 2 типа, артериальная гипертензия, атеросклероз, неалкогольная жировая болезнь печени и др. Основой патогенеза некоторых из них является развитие вторичной инсулинорезистентности. Механизмы влияния избытка жировой ткани на развитие резистентности к инсулину активно изучаются на протяжении последних десятилетий, однако до сих пор исследователями не получены ответы на все волнующие вопросы. В статье представлены основные механизмы развития инсулинорезистентности при ожирении и методы ее диагностики, а также актуальные данные исследований в ключе данной темы; рассмотрена тесная взаимосвязь инсулинорезистентности с развитием целого ряда ассоциированных с ожирением заболеваний, а именно – нарушениями углеводного обмена, дислипидемией, артериальной гипертензией, ишемической болезнью сердца, а также нарушениями репродуктивной функции как у женщин, так и у мужчин.</p></abstract><trans-abstract xml:lang="en"><p>The prevalence of obesity in the world is described as the global epidepic. Being not only a chronic recurrent disease but also a serious risk factor, obesity leads to the development and aggravation of many non-communicable diseases. Excessive amount and adipose tissue dysfunction in obesity determines the risk of the development of type 2 diabetes, arterial hypertension, atherosclerosis, non-alcoholic fatty liver disease etc. Secondary insulin resistance often underlies the development of the above mentioned conditions. The mechanisms contributing to the development of insulin resistance in case of excessive adipose tissue accumulation are being intensively investigated over the last decades, however many questions yet remain unsolved. In this article we present the key mechanisms underlying insulin resistance in obesity and diagnostic approaches for insulin resistance as well as the current data in this topic. The authors review the close links between insulin resistance and obesity related diseases, namely disorders of carbohydrate metabolism, dyslipidemia, arterial hypertension, coronary artery disease and reproductive disorders.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>ожирение</kwd><kwd>абдоминальное ожирение</kwd><kwd>инсулинорезистентность</kwd><kwd>сахарный диабет</kwd><kwd>жировая ткань</kwd><kwd>инсулин</kwd><kwd>дислипидемия</kwd><kwd>неалкогольная жировая болезнь печени</kwd><kwd>бесплодие</kwd></kwd-group><kwd-group xml:lang="en"><kwd>obesity</kwd><kwd>abdominal obesity</kwd><kwd>insulin resistance</kwd><kwd>diabetes</kwd><kwd>adipose tissue</kwd><kwd>insulin</kwd><kwd>dyslipidemia</kwd><kwd>nonalcoholic fatty liver disease</kwd><kwd>infertility</kwd><kwd>reproductive disorders</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Who.int [Internet]. Obesity and overweight [cited 2018 Jun 30]. Available from: http://www.who.int/mediacentre/factsheets/fs311/en/.</mixed-citation><mixed-citation xml:lang="en">Who.int [Internet]. Obesity and overweight [cited 2018 Jun 30]. Available from: http://www.who.int/mediacentre/factsheets/fs311/en/.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Муромцева Г.А., Концевая А.В., Константинов В.В., и др. Распространенность факторов риска неинфекционных заболеваний в российской популяции в 2012–2013 гг. Результаты исследования ЭССЕ-РФ. // Кардиоваскулярная терапия и профилактика. — 2014. — Т. 13. — № 6. — С. 4-11. [Muromtseva GA, Kontsevaya AV, Konstantinov VV, et. al. The prevalence of non-infectious diseases risk factors in Russian population in 2012-2013 years. The results of ECVD-RF. Cardiovascular therapy and prevention. 2014;13(6):4-11. (In Russ.)] doi: http://doi.org/10.15829/1728-8800-2014-6-4-11</mixed-citation><mixed-citation xml:lang="en">Муромцева Г.А., Концевая А.В., Константинов В.В., и др. Распространенность факторов риска неинфекционных заболеваний в российской популяции в 2012–2013 гг. Результаты исследования ЭССЕ-РФ. // Кардиоваскулярная терапия и профилактика. — 2014. — Т. 13. — № 6. — С. 4-11. [Muromtseva GA, Kontsevaya AV, Konstantinov VV, et. al. The prevalence of non-infectious diseases risk factors in Russian population in 2012-2013 years. The results of ECVD-RF. Cardiovascular therapy and prevention. 2014;13(6):4-11. (In Russ.)] doi: http://doi.org/10.15829/1728-8800-2014-6-4-11</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">International Diabetes Federation. IDF Diabetes Atlas. 9th ed. Brussels: IDF; 2019.</mixed-citation><mixed-citation xml:lang="en">International Diabetes Federation. IDF Diabetes Atlas. 9th ed. Brussels: IDF; 2019.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Дедов И.И., Шестакова М.В., Галстян Г.Р. Распространенность сахарного диабета 2 типа у взрослого населения России (исследование NATION). // Сахарный диабет. — 2016. — Т. 19. — №2. — С. 104-112. [Dedov II, Shestakova MV, Galstyan GR. The prevalence of type 2 diabetes mellitus in the adult population of Russia (NATION study). Diabetes mellitus. 2016;19(2):104-112. (In Russ.)] DOI:10.14341/DM2004116-17</mixed-citation><mixed-citation xml:lang="en">Дедов И.И., Шестакова М.В., Галстян Г.Р. Распространенность сахарного диабета 2 типа у взрослого населения России (исследование NATION). // Сахарный диабет. — 2016. — Т. 19. — №2. — С. 104-112. [Dedov II, Shestakova MV, Galstyan GR. The prevalence of type 2 diabetes mellitus in the adult population of Russia (NATION study). Diabetes mellitus. 2016;19(2):104-112. (In Russ.)] DOI:10.14341/DM2004116-17</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-419. DOI:10.1007/bf00280883</mixed-citation><mixed-citation xml:lang="en">Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-419. DOI:10.1007/bf00280883</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Vilela BS, Vasques AC, Cassani RS, et al. The HOMA-Adiponectin (HOMA-AD) Closely Mirrors the HOMA-IR Index in the Screening of Insulin Resistance in the Brazilian Metabolic Syndrome Study (BRAMS). PLoS One. 2016;11(8):e0158751. DOI:10.1371/journal.pone.0158751</mixed-citation><mixed-citation xml:lang="en">Vilela BS, Vasques AC, Cassani RS, et al. The HOMA-Adiponectin (HOMA-AD) Closely Mirrors the HOMA-IR Index in the Screening of Insulin Resistance in the Brazilian Metabolic Syndrome Study (BRAMS). PLoS One. 2016;11(8):e0158751. DOI:10.1371/journal.pone.0158751</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Ройтберг Г.Е., Дорош Ж.В., Шархун О.О., и др. Возможности применения нового метаболического индекса при оценке инсулинорезистентности в клинической практике. // Рациональная фармакотерапия в кардиологии. — 2014. — Т. 10. — №3. — С. 264-274. [Roytberg GE, Dorosh JV, Sharkhun OO, et al. New metabolic index use potentialities in evaluation of insulin resistance in clinical practice. Rational pharmacotherapy in cardiology. 2014;10(3):264-274. (In Russ.)] DOI:10.20996/1819-6446-2014-10-3-264-274</mixed-citation><mixed-citation xml:lang="en">Ройтберг Г.Е., Дорош Ж.В., Шархун О.О., и др. Возможности применения нового метаболического индекса при оценке инсулинорезистентности в клинической практике. // Рациональная фармакотерапия в кардиологии. — 2014. — Т. 10. — №3. — С. 264-274. [Roytberg GE, Dorosh JV, Sharkhun OO, et al. New metabolic index use potentialities in evaluation of insulin resistance in clinical practice. Rational pharmacotherapy in cardiology. 2014;10(3):264-274. (In Russ.)] DOI:10.20996/1819-6446-2014-10-3-264-274</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Николаев А.Я., Осипов Е.В., Кцоева С.А. Биохимия инсулинозависимого сахарного диабета. — М.: Медицина; 2000. [Nikolaev AY, Osipov EV, Ktsoeva SA. Biokhimia insulinozavisimogo sakharnogo diabeta. Moscow: Meditsina; 2000. (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Николаев А.Я., Осипов Е.В., Кцоева С.А. Биохимия инсулинозависимого сахарного диабета. — М.: Медицина; 2000. [Nikolaev AY, Osipov EV, Ktsoeva SA. Biokhimia insulinozavisimogo sakharnogo diabeta. Moscow: Meditsina; 2000. (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Britton KA, Pedley A, Massaro JM, et al. Prevalence, distribution, and risk factor correlates of high thoracic periaortic fat in the Framingham Heart Study. J Am Heart Assoc. 2012;1(6):e004200. DOI:10.1161/JAHA.112.004200</mixed-citation><mixed-citation xml:lang="en">Britton KA, Pedley A, Massaro JM, et al. Prevalence, distribution, and risk factor correlates of high thoracic periaortic fat in the Framingham Heart Study. J Am Heart Assoc. 2012;1(6):e004200. DOI:10.1161/JAHA.112.004200</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Cheng KH, Chu CS, Lee KT, et al. Adipocytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease. Int J Obes (Lond). 2008;32(2):268-274. DOI:10.1038/sj.ijo.0803726</mixed-citation><mixed-citation xml:lang="en">Cheng KH, Chu CS, Lee KT, et al. Adipocytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease. Int J Obes (Lond). 2008;32(2):268-274. DOI:10.1038/sj.ijo.0803726</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Дедов И.И., Мельниченко Г.А., Бутрова С.А. Жировая ткань как эндокринный орган. // Ожирение и метаболизм. — 2006. — Т. 3. — №1. — C. 6-13. [Dedov II, Mel’nichenko GA, Butrova SA. Zhirovaya tkan’ kak endokrinnyy organ. Obesity and metabolism. 2006;3(1):6-13. (In Russ.)] DOI:10.14341/2071-8713-49375</mixed-citation><mixed-citation xml:lang="en">Дедов И.И., Мельниченко Г.А., Бутрова С.А. Жировая ткань как эндокринный орган. // Ожирение и метаболизм. — 2006. — Т. 3. — №1. — C. 6-13. [Dedov II, Mel’nichenko GA, Butrova SA. Zhirovaya tkan’ kak endokrinnyy organ. Obesity and metabolism. 2006;3(1):6-13. (In Russ.)] DOI:10.14341/2071-8713-49375</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Szasz T, Bomfim GF, Webb RC. The influence of perivascular adipose tissue on vascular homeostasis. Vasc Health Risk Manag. 2013;9:105-116. DOI:10.2147/VHRM.S33760</mixed-citation><mixed-citation xml:lang="en">Szasz T, Bomfim GF, Webb RC. The influence of perivascular adipose tissue on vascular homeostasis. Vasc Health Risk Manag. 2013;9:105-116. DOI:10.2147/VHRM.S33760</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Reaven GM. Pathophysiology of insulin resistance in human disease. Physiol Rev. 1995;75(3):473-486. DOI:10.1152/physrev.1995.75.3.473</mixed-citation><mixed-citation xml:lang="en">Reaven GM. Pathophysiology of insulin resistance in human disease. Physiol Rev. 1995;75(3):473-486. DOI:10.1152/physrev.1995.75.3.473</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Baratta R, Amato S, Degano C, et al. Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and intervention studies. J Clin Endocrinol Metab. 2004;89(6):2665-2671. DOI:10.1210/jc.2003-031777</mixed-citation><mixed-citation xml:lang="en">Baratta R, Amato S, Degano C, et al. Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and intervention studies. J Clin Endocrinol Metab. 2004;89(6):2665-2671. DOI:10.1210/jc.2003-031777</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Скудаева Е.С., Пашенцева А.В., Вербовой А.Ф. Уровни резистина, адипонектина и инсулинорезистентности у пациентов с разной степенью нарушений углеводного обмена. // Ожирение и метаболизм. — 2011. — Т. 8. — №3. — С. 57-60. [Skudaeva ES, Pashentseva AV, Verbovoy AF. Urovni resistina, adiponektina I insulinorezistentnosti u patsientov s raznoy stepen`u narusheniy uglevodnogo obmena. Obesity and metabolism. 2011;8(3):57-60. (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Скудаева Е.С., Пашенцева А.В., Вербовой А.Ф. Уровни резистина, адипонектина и инсулинорезистентности у пациентов с разной степенью нарушений углеводного обмена. // Ожирение и метаболизм. — 2011. — Т. 8. — №3. — С. 57-60. [Skudaeva ES, Pashentseva AV, Verbovoy AF. Urovni resistina, adiponektina I insulinorezistentnosti u patsientov s raznoy stepen`u narusheniy uglevodnogo obmena. Obesity and metabolism. 2011;8(3):57-60. (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Osegbe I, Okpara H, Azinge E. Relationship between serum leptin and insulin resistance among obese Nigerian women. Ann Afr Med. 2016;15(1):14-19. DOI:10.4103/1596-3519.158524</mixed-citation><mixed-citation xml:lang="en">Osegbe I, Okpara H, Azinge E. Relationship between serum leptin and insulin resistance among obese Nigerian women. Ann Afr Med. 2016;15(1):14-19. DOI:10.4103/1596-3519.158524</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Bonora E, Kiechl S, Willeit J, et al. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes. 1998;47(10):1643-1649. DOI:10.2337/diabetes.47.10.1643</mixed-citation><mixed-citation xml:lang="en">Bonora E, Kiechl S, Willeit J, et al. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes. 1998;47(10):1643-1649. DOI:10.2337/diabetes.47.10.1643</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Skarfors ET, Lithell HO, Selinus I. Risk factors for the development of hypertension: a 10-year longitudinal study in middle-aged men. J Hypertens. 1991;9(3):217-223. DOI:10.1097/00004872-199103000-00004</mixed-citation><mixed-citation xml:lang="en">Skarfors ET, Lithell HO, Selinus I. Risk factors for the development of hypertension: a 10-year longitudinal study in middle-aged men. J Hypertens. 1991;9(3):217-223. DOI:10.1097/00004872-199103000-00004</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Корнеева О.Н., Драпкина О.М. Патогенетические взаимосвязи артериальной гипертензии и инсулинорезистентности. // Российский кардиологический журнал. — 2006. — Т. 11. — №5. — С. 100-103. [Korneeva ON, Drapkina OM. Pathogenetic interaction of arterial hypertension and insulin resistance. Russian journal of cardiology. 2006;11(5):100-103. (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Корнеева О.Н., Драпкина О.М. Патогенетические взаимосвязи артериальной гипертензии и инсулинорезистентности. // Российский кардиологический журнал. — 2006. — Т. 11. — №5. — С. 100-103. [Korneeva ON, Drapkina OM. Pathogenetic interaction of arterial hypertension and insulin resistance. Russian journal of cardiology. 2006;11(5):100-103. (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Груздева О.В., Каретникова В.Н., Учасова Е.Г., и др. Инсулинорезистентность и риск неблагоприятного исхода через 1 год после перенесенного инфаркта миокарда. // Врач. — 2015. — №12. — С. 30-34. [Gruzdeva OV, Karetnikova VN, Uchasova EG, et. al. Insulin resistance and a risk for poor outcome one year after myocardial infarction. Vrach. 2015;(12):30-34. (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Груздева О.В., Каретникова В.Н., Учасова Е.Г., и др. Инсулинорезистентность и риск неблагоприятного исхода через 1 год после перенесенного инфаркта миокарда. // Врач. — 2015. — №12. — С. 30-34. [Gruzdeva OV, Karetnikova VN, Uchasova EG, et. al. Insulin resistance and a risk for poor outcome one year after myocardial infarction. Vrach. 2015;(12):30-34. (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Potter van Loon BJ, Kluft C, Radder JK, et al. The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance. Metabolism. 1993;42(8):945-949. DOI:10.1016/0026-0495(93)90005-9</mixed-citation><mixed-citation xml:lang="en">Potter van Loon BJ, Kluft C, Radder JK, et al. The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance. Metabolism. 1993;42(8):945-949. DOI:10.1016/0026-0495(93)90005-9</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Hu P, Zhang D, Swenson L, et al. Minimally invasive aortic banding in mice: effects of altered cardiomyocyte insulin signaling during pressure overload. Am J Physiol Heart Circ Physiol. 2003;285(3):H1261-1269. DOI:10.1152/ajpheart.00108.2003</mixed-citation><mixed-citation xml:lang="en">Hu P, Zhang D, Swenson L, et al. Minimally invasive aortic banding in mice: effects of altered cardiomyocyte insulin signaling during pressure overload. Am J Physiol Heart Circ Physiol. 2003;285(3):H1261-1269. DOI:10.1152/ajpheart.00108.2003</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Despres JP, Lamarche B, Mauriege P, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 1996;334(15):952-957. DOI:10.1056/NEJM199604113341504</mixed-citation><mixed-citation xml:lang="en">Despres JP, Lamarche B, Mauriege P, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 1996;334(15):952-957. DOI:10.1056/NEJM199604113341504</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Драпкина О.М., Ивашкин В.Т. Эпидемиологические особенности неалкогольной жировой болезни печени в России (результаты открытого многоцентрового проспективного исследования наблюдения DIREGL 01903). // Российский журнал гастроэнтерологии, гепатологии, колопроктологии. — 2014. — Т. 24. — №4. — С. 32-38. [Drapkina OM, Ivashkin VT. Epidemiologicheskie osobennosti nealkogol’noy zhirovoy bolezni pecheni v Rossii (rezul’taty otkrytogo mnogotsentrovogo prospektivnogo issledovaniya nablyudeniya DIREGL 01903). Russian journal of gastroenterology, hepatology, coloproctology. 2014;24(4):32-38 (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Драпкина О.М., Ивашкин В.Т. Эпидемиологические особенности неалкогольной жировой болезни печени в России (результаты открытого многоцентрового проспективного исследования наблюдения DIREGL 01903). // Российский журнал гастроэнтерологии, гепатологии, колопроктологии. — 2014. — Т. 24. — №4. — С. 32-38. [Drapkina OM, Ivashkin VT. Epidemiologicheskie osobennosti nealkogol’noy zhirovoy bolezni pecheni v Rossii (rezul’taty otkrytogo mnogotsentrovogo prospektivnogo issledovaniya nablyudeniya DIREGL 01903). Russian journal of gastroenterology, hepatology, coloproctology. 2014;24(4):32-38 (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Adams LA, Angulo P, Lindor KD. Nonalcoholic fatty liver disease. CMAJ. 2005;172(7):899-905. DOI:10.1503/cmaj.045232</mixed-citation><mixed-citation xml:lang="en">Adams LA, Angulo P, Lindor KD. Nonalcoholic fatty liver disease. CMAJ. 2005;172(7):899-905. DOI:10.1503/cmaj.045232</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Targher G, Marchesini G, Byrne CD. Risk of type 2 diabetes in patients with non-alcoholic fatty liver disease: Causal association or epiphenomenon? Diabetes Metab. 2016;42(3):142-156. DOI:10.1016/j.diabet.2016.04.002</mixed-citation><mixed-citation xml:lang="en">Targher G, Marchesini G, Byrne CD. Risk of type 2 diabetes in patients with non-alcoholic fatty liver disease: Causal association or epiphenomenon? Diabetes Metab. 2016;42(3):142-156. DOI:10.1016/j.diabet.2016.04.002</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Pasquali R, Gambineri A, Pagotto U. The impact of obesity on reproduction in women with polycystic ovary syndrome. BJOG. 2006;113(10):1148-1159. DOI:10.1111/j.1471-0528.2006.00990.x</mixed-citation><mixed-citation xml:lang="en">Pasquali R, Gambineri A, Pagotto U. The impact of obesity on reproduction in women with polycystic ovary syndrome. BJOG. 2006;113(10):1148-1159. DOI:10.1111/j.1471-0528.2006.00990.x</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Шибанова Е.И. Клинико-иммунологические аспекты инсулинорезистентности во время беременности: Автореф. дис. … канд. мед. наук. — М., 2009. [Shibanova EI. Kliniko-immunologicheskie aspekty insulinorezistentnosti vo vremya beremennosti. [dissertation] Moscow; 2009. (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Шибанова Е.И. Клинико-иммунологические аспекты инсулинорезистентности во время беременности: Автореф. дис. … канд. мед. наук. — М., 2009. [Shibanova EI. Kliniko-immunologicheskie aspekty insulinorezistentnosti vo vremya beremennosti. [dissertation] Moscow; 2009. (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Ohwaki K, Endo F, Yano E. Relationship between body mass index and infertility in healthy male Japanese workers: a pilot study. Andrologia. 2009;41(2):100-104. DOI:10.1111/j.1439-0272.2008.00896.x</mixed-citation><mixed-citation xml:lang="en">Ohwaki K, Endo F, Yano E. Relationship between body mass index and infertility in healthy male Japanese workers: a pilot study. Andrologia. 2009;41(2):100-104. DOI:10.1111/j.1439-0272.2008.00896.x</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Nguyen RH, Wilcox AJ, Skjaerven R, Baird DD. Men’s body mass index and infertility. Hum Reprod. 2007;22(9):2488-2493. DOI:10.1093/humrep/dem139</mixed-citation><mixed-citation xml:lang="en">Nguyen RH, Wilcox AJ, Skjaerven R, Baird DD. Men’s body mass index and infertility. Hum Reprod. 2007;22(9):2488-2493. DOI:10.1093/humrep/dem139</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
